Koate and Ramucirumab Intravenous
Determining the interaction of Koate and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Koate-Ranexa
- Koate-Ranibizumab
- Koate-Ranibizumab Intraocular
- Koate-Ranibizumab ophthalmic
- Koate-Ranitidine
- Koate-Ranitidine Capsule
- Ramucirumab Intravenous-Koate-DVI
- Ramucirumab Intravenous-Koate-DVI human
- Ramucirumab Intravenous-Kogenate FS
- Ramucirumab Intravenous-Kogenate FS Bio-Set
- Ramucirumab Intravenous-Kogenate FS recombinant
- Ramucirumab Intravenous-Kola-Pectin